Cargando…
Discovery of re-purposed drugs that slow SARS-CoV-2 replication in human cells
COVID-19 vaccines based on the Spike protein of SARS-CoV-2 have been developed that appear to be largely successful in stopping infection. However, therapeutics that can help manage the disease are still required until immunity has been achieved globally. The identification of repurposed drugs that...
Autores principales: | Pickard, Adam, Calverley, Ben C., Chang, Joan, Garva, Richa, Gago, Sara, Lu, Yinhui, Kadler, Karl E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428568/ https://www.ncbi.nlm.nih.gov/pubmed/34499689 http://dx.doi.org/10.1371/journal.ppat.1009840 |
Ejemplares similares
-
Preservation of circadian rhythms by the protein folding chaperone, BiP
por: Pickard, Adam, et al.
Publicado: (2019) -
Dynamic High-Sensitivity Quantitation of Procollagen-I by Endogenous CRISPR-Cas9 NanoLuciferase Tagging
por: Calverley, Ben C., et al.
Publicado: (2020) -
Slow Stretching That Mimics Embryonic Growth Rate Stimulates Structural and Mechanical Development of Tendon-Like Tissue In Vitro
por: Kalson, Nicholas S, et al.
Publicado: (2011) -
Arhgap28 Is a RhoGAP that Inactivates RhoA and Downregulates Stress Fibers
por: Yeung, Ching-Yan Chloé, et al.
Publicado: (2014) -
Stepwise proteolytic activation of type I procollagen to collagen within the secretory pathway of tendon fibroblasts in situ
por: Canty-Laird, Elizabeth G., et al.
Publicado: (2011)